Therefore, several studies have already reported the effectiveness of CCR5 antagonist drugs in proposing measures against HIV-1 infection, corroborating the findings of this review for associated with factors, such as neurological complications [94]. The gene discussed is CCR5; the disease is HIV-1 infection.